Literature DB >> 18350632

Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Shu-Jie Chen1, Liang-Jing Wang, Qin Zhu, Jian-Ting Cai, Tao Chen, Jian-Min Si.   

Abstract

AIM: To investigate the relationship between H pylori infection, blood ammonia concentration and hepatic encephalopathy (HE), and the effect of H pylori eradication in cirrhotic patients.
METHODS: From July 2003 to January 2005, 457 cirrhotic patients in five regions of Zhejiang Province were enrolled. Patients were evaluated for demographics, number connection test, H pylori infection, liver impairment, blood ammonia concentration and HE. Patients with H pylori infection were given 1 wk therapy with omeprazole plus clarithromycin and tinidazole. (14)C urea breath test was performed and mental symptoms and blood ammonia level were reassessed after bacterium eradication.
RESULTS: Overall H pylori infection rate was 60.6%, and HE occurred in 47.5% of cirrhotic patients. Subclinical HE (SHE) was detected in 55 of 117 cirrhotic patients. Blood ammonia concentration in H pylori negative (n = 180) and positive (n = 277) cirrhotic patients was 53.8 +/- 51.4 and 78.4 +/- 63.6 mumol/L, respectively (P < 0.01), which was significantly reduced to 53.5 +/- 37.7 mumol/L after bacterium eradication (n = 126) (P < 0.01). Blood ammonia was 97.5 +/- 81.0 mumol/L in H pylori-positive cirrhotic patients, and this did not significantly change in those with persistent infection after H pylori eradication (n = 11). HE was more frequently observed in patients with H pylori infection than in those without (58.5% vs 30.6%, P < 0.01). HE rate significantly dropped to 34.1% after H pylori eradiation (P < 0.01). H pylori prevalence significantly differed among cirrhotic patients with HE (74.4%), SHE (69.1%), and those without HE (53.2%) (P < 0.05). Blood ammonia level was significantly different among cirrhotic patients with HE (94.5 +/- 75.6 mumol/L), SHE (59.9 +/- 49.2 mumol/L), and without HE (47.3 +/- 33.5 mumol/L) (P < 0.05). Logistic regression analysis showed that blood ammonia concentration, Child-Pugh stage, upper gastrointestinal bleeding, electrolyte disturbance, and urea nitrogen were risk factors for HE.
CONCLUSION: H pylori infection is an important factor for inducing high blood ammonia concentration and HE in cirrhotic patients. H pylori eradication may be helpful for treatment and prevention of HE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350632      PMCID: PMC2700403          DOI: 10.3748/wjg.14.1914

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  The effect of Helicobacter pylori eradication on gastric juice and blood ammonia concentrations and on visual evoked potentials in cirrhotics.

Authors:  L Demirtürk; Y Yazgan; O zci; M Ozel; E Toğrol; M Gültepe; A K Gürbüz; S Yildirim
Journal:  Helicobacter       Date:  2001-12       Impact factor: 5.753

2.  Helicobacter pylori infection induces hyperammonaemia in Mongolian gerbils with liver cirrhosis.

Authors:  H Suto; T Azuma; S Ito; M Ohtani; M Dojo; Y Ito; Y Kohli; M Kuriyama
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

3.  Hyperammonaemia and Helicobacter pylori.

Authors:  S Ito; H Miyaji; T Azuma; Y Li; Y Ito; T Kato; Y Kohli; M Kuriyama
Journal:  Lancet       Date:  1995-07-08       Impact factor: 79.321

4.  Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.

Authors:  M Huber; M Rössle; V Siegerstetter; A Ochs; K Haag; M Kist; H E Blum
Journal:  Hepatogastroenterology       Date:  2001 Mar-Apr

5.  Helicobacter pylori infection, plasma ammonia levels, and psychometric testing in cirrhotic patients.

Authors:  A Zullo; V Rinaldi; P Meddi; C Hassan; S Winn; A F Attili
Journal:  Am J Gastroenterol       Date:  1999-08       Impact factor: 10.864

6.  Breath and blood ammonia in liver cirrhosis.

Authors:  C Shimamoto; I Hirata; K Katsu
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

7.  Association between Helicobacter pylori infection and cirrhosis in patients with chronic hepatitis C virus.

Authors:  Dulciene Maria Magalhães Queiroz; Andreia Maria Camargos Rocha; Gifone Aguiar Rocha; Sarah Maria Singulano Cinque; Adriana Gonçalves Oliveira; Alicia Godoy; Hugo Tanno
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

8.  Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275.

Authors:  G P Gubbins; T E Moritz; L S Marsano; R Talwalkar; C J McClain; C L Mendenhall
Journal:  Am J Gastroenterol       Date:  1993-11       Impact factor: 10.864

9.  Reversal of migraine symptoms by Helicobacter pylori eradication therapy in patients with hepatitis-B-related liver cirrhosis.

Authors:  Liu Hong; Yunping Zhao; Ying Han; Wei Guo; Jun Wang; Xiaohua Li; Yu Han; Daiming Fan
Journal:  Helicobacter       Date:  2007-08       Impact factor: 5.753

10.  Correlations among gastric juice pH and ammonia, Helicobacter pylori infection and gastric mucosal histology.

Authors:  Ok-Jae Lee; Eun-Jung Lee; Hyun-Jin Kim
Journal:  Korean J Intern Med       Date:  2004-12       Impact factor: 2.884

View more
  8 in total

Review 1.  Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA.

Authors:  Peter Nagy; Saga Johansson; Michael Molloy-Bland
Journal:  Gut Pathog       Date:  2016-03-15       Impact factor: 4.181

2.  Helicobacter pylori infection among patients with liver cirrhosis.

Authors:  Joanna Pogorzelska; Magda Łapińska; Alicja Kalinowska; Tadeusz W Łapiński; Robert Flisiak
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-10       Impact factor: 2.566

Review 3.  A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2018-05-24

Review 4.  Use Of Quantitative Modelling To Elucidate The Roles Of The Liver, Gut, Kidney, And Muscle In Ammonia Homeostasis And How Lactulose And Rifaximin Alter This Homeostasis.

Authors:  Michael D Levitt; David G Levitt
Journal:  Int J Gen Med       Date:  2019-10-14

Review 5.  Hepatic encephalopathy.

Authors:  Wissam Bleibel; Abdullah M S Al-Osaimi
Journal:  Saudi J Gastroenterol       Date:  2012 Sep-Oct       Impact factor: 2.485

6.  Association of Helicobacter pylori with elevated blood ammonia levels in cirrhotic patients: a meta-analysis.

Authors:  Hai-Xing Jiang; Shan-Yu Qin; Zhi-gang Min; Ming-Zhi Xie; Tao Lin; Bang-Li Hu; Xiao-Yun Guo
Journal:  Yonsei Med J       Date:  2013-07       Impact factor: 2.759

7.  Erythromycin versus neomycin in the treatment of hepatic encephalopathy in cirrhosis: a randomized double-blind study.

Authors:  Fernando Gomes Romeiro; Fabio da Silva Yamashiro; Madileine Francely Américo; Luciana Aparecida Corá; Giovanni Faria Silva; José Ricardo de Arruda Miranda; Carlos Antonio Caramori
Journal:  BMC Gastroenterol       Date:  2013-01-16       Impact factor: 3.067

Review 8.  Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Authors:  Liliana Rivera-Espinosa; Esaú Floriano-Sánchez; José Pedraza-Chaverrí; Elvia Coballase-Urrutia; Aristides Iii Sampieri; Daniel Ortega-Cuellar; Noemí Cárdenas-Rodríguez; Liliana Carmona-Aparicio
Journal:  Int J Mol Sci       Date:  2013-08-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.